Chemical Structure (Kimyrsa 01)
Kimyrsa Injection, Powder, Lyophilized, For Solution
Product Images NDC 70842-225
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Kimyrsa (NDC 70842-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Melinta Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (1,200 mg Vial Carton)
This text seems to be a package insert for a medical product called Kimyrsa. The recommended dosage for this product is one dose administered as a single intravenous infusion over 1 hour. The vial contains 1,200 mg of orifavancin. The product must be reconstituted and further diluted to a final volume of 250 mL. The rest of the text includes instructions for storage and disposal, as well as information about the manufacturer and lot numbers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
